Pacific Biosciences of California PACB Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's other noncash income (expense)?
- Pacific Biosciences of California (PACB) reported other noncash income (expense) of -$225K in Q1 2026.
- How has Pacific Biosciences of California's other noncash income (expense) changed year-over-year?
- Pacific Biosciences of California's other noncash income (expense) increased by 68.7% year-over-year, from -$719K to -$225K.
- What is the long-term trend for Pacific Biosciences of California's other noncash income (expense)?
- Over 2 years (2023 to 2025), Pacific Biosciences of California's other noncash income (expense) has grown at a 26.3% compound annual growth rate (CAGR), from -$1.06M to -$1.69M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.